This study was undertaken to determine whether abnormalities on the echocardiograms of patients with unstable angina have any prognostic significance. 27 male patients, mean age 53 years, who fulfilled criteria for unstable angina and who responded to medical therapy, had echocardiograms within 48 h of admission and at discharge. Follow-up data were obtained from 7 patients during a postdischarge period of 6–26 weeks. 13 patients had mild exertional angina or were pain-free (group I) and 14 patients had either severe, stable angina pectoris or recurrence of their unstable angina (group II) during the follow-up period. When admission and discharge values were compared, the echocardiographic ratio of left ventricular end-diastolic dimension to mitral valve closure time (EDD/PR-AC) showed significant differences for both group I and group II (p < 0.05). An abnormal EDD/PR-AC ratio was present at discharge in 8 of 14 group II patients compared to only 1 of 13 group I patients (p < 0.05). The mean values for end-diastolic dimension, mitral valve closure time, and amplitudes of interventricular septal and posterior left ventricular wall motion were not significantly different in comparisons between admission and discharge studies and between group I and group II patients. In 19 patients who had cardiac catheterization during the follow-up period, the discharge EDD/PR-AC ratio correlated inversely with the angiographic ejection fraction (r = 0.79; p < 0.001).

Keywords:
Unstable angina, Echocardiography, Prognosis after unstable angina
This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.